C07D 495/06
Peri-condensed systems
C07D495/06 (Peri-condensed systems) appears on 127 US grants and 117 published applications in this corpus.
Search patents in C07D- Granted patents
- 127
- Published applications
- 117
- Assignees
- 77
- Inventors
- 346
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 5 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 5 | 2 |
| 2004 | 1 | 5 |
| 2005 | 2 | 6 |
| 2006 | 3 | 7 |
| 2007 | 6 | 6 |
| 2008 | 5 | 6 |
| 2009 | 2 | 3 |
| 2010 | 1 | 1 |
| 2011 | 3 | 1 |
| 2012 | 2 | 4 |
| 2013 | 1 | 2 |
| 2014 | 2 | 6 |
| 2015 | 7 | 4 |
| 2016 | 4 | 5 |
| 2017 | 7 | 8 |
| 2018 | 4 | 7 |
| 2019 | 6 | 10 |
| 2020 | 3 | 7 |
| 2021 | 2 | 5 |
| 2022 | 3 | 6 |
| 2023 | 4 | 5 |
| 2024 | 2 | 3 |
| 2025 | 6 | 3 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyclic compounds for organic electroluminescent devices9 Jun 2026US 12,652,954 B2Universal Display Corporation
- Luminescent compound, method for producing luminescent compound, luminescent composition, luminescent thin film and luminescent particles21 Apr 2026US 12,606,739 B2Konica Minolta, Inc.
- Compounds, compositions, and methods for treating fibrosis10 Mar 2026US 12,570,670 B2Yale University
- Protein degraders and uses thereof28 Oct 2025US 12,454,520 B2Kymera Therapeutics, Inc.
- Materials for organic electroluminescent devices30 Sep 2025US 12,433,160 B2Merck Patent GmbH
- Cyclic compounds for organic electroluminescent devices24 Sep 2026US 2026/0293520 A1UDC Ireland Limited
- Treatment of signs, symptoms and/or complications of viral, bacterial, protozoal, and/or fungal infections by high penetration prodrugs27 Aug 2026US 2026/0248922 A1Techfields Inc.
- Compounds, compositions, and methods for treating fibrosis16 Jul 2026US 2026/0200938 A1
- Organic electroluminescent compound and organic electroluminescent device comprising the same14 May 2026US 2026/0136829 A1
- Protein degraders and uses thereof25 Dec 2025US 2025/0388566 A1Kymera Therapeutics, Inc.
Most cited
By later US patents
- Substituted heterocycle fused gamma-carbolines138US 6,552,017 B1Bristol-Myers Squibb Pharma Company · 2003
- Substituted heterocycle fused gamma-carbolines131US 6,548,493 B1Bristol-Myers Squibb Pharma Company · 2003
- Substituted heterocycle fused gamma-carbolines122US 6,713,471 B1Bristol-Myers Squibb Pharma Company · 2004
- Substituted heterocycle fused gamma-carbolines105US 7,071,186 B2Bristol-Myers Squibb Pharma Company · 2006
- Substituted heterocycle fused γ-carbolines103US 7,183,282 B2Bristol-Myers Squibb Pharma Company · 2007